The potential of Melatonin in the practice of a neurologist: A scientific view.

On October 16, 2024, at 17:00, a webinar "The potential of melatonin in the practice of a neurologist: a scientific view" was held for neurologists, general practitioners, internists, as well as residents of the department.  The webinar was conducted by Nurguzhaev Yerkin  Smagulovich, MD, Professor of the Department of Nervous Diseases of KazNMU named after S.D. Asfendiyarov, President of the Public association "Association of Neurologists" of the Republic of Kazakhstan.  

VI International Congress of the Turkic World on Multiple Sclerosis

   On October 7-9, 2024, the VI International Congress of the Turkic World on Multiple Sclerosis was held in the Turkish Republic of Northern Cyprus.   

II National Interdisciplinary Congress with international participation "Comorbid Neurology 2024"

On October 11-12, 2024, Moscow hosted the II National Interdisciplinary Congress with international participation "Comorbid Neurology 2024" ‒ a landmark event in the world of neurology, bringing together leading Russian and international experts. 

Orphan diseases of the central nervous system. Diagnostics and dynamic monitoring of adult patients with Spinal muscular atrophy (SMA)

The Department of Nervous Diseases of KazNMU named after S.D.Asfendiyarov in the year of its 90th anniversary continues a series of educational events for practical healthcare dedicated to the 135th anniversary of S.D. Asfendiyarov and the 120th anniversary of Professor M.H.Farizov.

Innovative technologies in neurology and related specialties

Scientific supervisors and chairmen: V.I. Shmyrev, MD, Professor, member of the Presidium of the All-Russian Society of Neurologists, Chief Specialist in Neurology of the Main Medical Department of the Presidential Administration of the Russian Federation, Head of the Department of Neurology of the Federal State Budgetary Institution DPO "CGMA" of the Presidential Administration of the Russian Federation.

International Expert Council "Possibilities of using neuroprotective medications in ischemic stroke"

From October 27 to October 1, 2024, an International Expert Council "Possibilities of using neuroprotective medications in ischemic stroke" was held in Samarkand (Republic of Uzbekistan). The main purpose of the expert council was to discuss the results of a randomized double-blind multicenter placebo-controlled parallel group study of the efficacy and safety of Mexidol® in long-term sequential therapy in patients with acute and early recovery periods of hemispheric ischemic stroke.